Gemphire Therapeutics' IPO

Gemphire Therapeutics raised a round of funding on August 05, 2016. Investors include Public.

Gemphire Therapeutics is a clinical-stage biotech company. The company offers, Gemcabene, an oral once-daily drug candidate, that is being developed to treat the large unmet medical need of patients w…

Articles about Gemphire Therapeutics' IPO: